Order ACTOVEGIN TABLETS AND Injectable Ampoules

Actovegin 200 mg/5 ml, 5 ampoules, Takeda

Price: 100 EURO box + shipping

Order: sales@gerovital-gh3.com

tel: +40723141550 whatsapp 

Indications:

Prophylaxis and treatment of cerebral circulatory and trophic disorders (ischemic stroke, treatment of craniocerebral trauma).

Prophylaxis and treatment of peripheral vascular diseases (arterial or venous) and their sequelae (arterial angiopathies and varicose ulcers).

Treatment of skin grafts.

Treatment of burns, skin erosions and lesions caused by contact with hot liquids.

Treatment of wounds in patients with impaired recovery: torpid skin or mucosal ulcers and decubitus ulcers.

Prophylaxis and treatment of skin-mucosal lesions induced by radiotherapy.

Contraindications:

Do not use Actovegin:

- if you are allergic to deproteinized hemoderivate from calf blood or to any of the other components of this medicine.

Precautions:

Before using Actovegin, consult your doctor or pharmacist.

Pregnancy, breast-feeding and fertility:

If you are pregnant or breast-feeding, think you may be pregnant or are planning to become pregnant, ask your doctor or pharmacist for advice before taking this medicine.

The use of Actovegin in humans has not shown any adverse effects on the mother or the child. However, the therapeutic benefits of Actovegin should be weighed against the potential risks to the child.

Driving and using machines:

Actovegin does not affect the ability to drive or use machines.

Composition:

- The active substance is deproteinized hemoderivative from calf blood. 5 ml of solution for injection contains deproteinized hemoderivative from calf blood (expressed as dry matter) 200 mg as a concentrated solution 1113 mg.

- The other ingredients are: water for injections, hydrochloric acid 1M.

Presentation: 5 ampoules

How to use:

Always use this medicine exactly as your doctor or pharmacist has told you. Talk to your doctor or pharmacist if you are not sure.

Actovegin 200 mg/5 ml, 5 ampoules, Takeda

Price: 100 EURO box + shipping

Order: sales@gerovital-gh3.com

tel: +40723141550 whatsapp 

Dosage:

Actovegin - solution for injection is administered intravenously, intramuscularly or intraarterially and is added to infusion solutions.

a) General indications for administration:

Treatment with Actovegin is adjusted depending on the severity of the clinical picture. Treatment is initiated with 400-800 mg of deproteinized hemoderivative from calf blood (10-20 ml of Actovegin injection solution) per day, administered intravenously, intraarterially or by infusion. In maintenance therapy, 200 mg of deproteinized hemoderivative from calf blood (5 ml of Actovegin injection solution) is administered intravenously daily or slowly intramuscularly several times a week.

For infusion administration, 400-2000 mg of deproteinized calf blood hemoderivative (10-50 ml of Actovegin injection solution) is added to 200-300 ml of base solution (isotonic NaCl solution or 5% glucose solution). The administration rate is approximately 2 ml per minute.

b) Dosage according to indication:

Cerebral circulatory and trophic disorders: the recommended initial dose is 400 mg of deproteinized calf blood hemoderivative (10 ml of Actovegin injection solution) per day, administered intravenously for two weeks, then continued with 200-400 mg of deproteinized calf blood hemoderivative (5-10 ml of Actovegin injection solution) administered intravenously several times a week for 4 weeks.

Ischemic stroke: the recommended dose is 800-2000 mg of deproteinized hemoderivative from calf blood (20-50 ml of Actovegin injection solution), administered by infusion in 200-300 ml of base solution, daily or several times a week, for two to three weeks.

Arteriopathies: the recommended dose is 800-2000 mg of deproteinized hemoderivative from calf blood (20-50 ml of Actovegin injection solution), administered by infusion, intraarterially or intravenously, daily or several times a week, for four weeks.

Treatment of varicose ulcers or other types of ulcers: the recommended dose is 400 mg of deproteinized hemoderivative from calf blood (10 ml of Actovegin injectable solution), administered intravenously or 200 mg of deproteinized hemoderivative from calf blood (5 ml of Actovegin injectable solution) administered intramuscularly,

daily or several times a week, depending on the progress of the healing process, possibly associated with topical treatment with Actovegin.

Prophylaxis and treatment of skin-mucosal lesions induced by irradiation: the recommended dose is 200 mg of deproteinized hemoderivative from calf blood (5 ml of Actovegin injectable solution) administered intravenously, daily during the irradiation period.

Treatment of radiogenic cystitis: the recommended dose is 400 mg of deproteinized hemoderivative from calf blood (10 ml of Actovegin injectable solution) administered daily, transurethral, ​​in association with antibiotic therapy.